Leading Ukrainian pharmaceutical manufacturer Farmak joined the world’s largest conference, the Radiological Society of North America (RSNA) event, which took place November 26-30 in Chicago.
The Radiological Society of North America is a non-profit organization and an international society of radiologists, medical physicists, and other medical imaging professionals representing 31 radiologic subspecialties from 145 countries around the world. The annual conference of this society brings together radiologists, scientists, engineers, and representatives of pharmaceutical companies.
RSNA members present new radio diagnostic technologies, research findings, and innovations in the use of medical imaging for diagnosis and treatment. The conference also discusses standards, protocols, and best practices in the field of radiology.
Farmak, as a conference participant, presented the visitors with its own medicines, which are used in magnetic resonance imaging and radiocontrast therapy. These drugs are used to study organs and systems of the body during MRI, X-ray, and other methods of Diagnostic Imaging.
In the updated Farmak 2.0 strategy, the company declared its main strategic priorities and goals until 2028, including entering the US market with contrast media products. Thus, participation in RSNA 2023 is an excellent occasion to present medicines from Farmak to the professional community from all over the world.
